Current issues and trends in the diagnosis and treatment of adults with ADHD

References

• Spencer TJ, Biederman J, Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. Ambul. Pediatr.7(Suppl. 1), 73–81 (2007).
   PubMedGoogle Scholar
• Faraone SV, Biederman J, What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J. Atten. Disord.9(2), 384–391 (2005).
   PubMedGoogle Scholar
• Kessler RC, Adler LA, Ames M et al. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J. Occup. Environ. Med.47(6), 565–572 (2005).
   PubMed Web of Science ®Google Scholar
• Weiss G, Hechtman L. In:Hyperactive Children Grown up: ADHD in Children, Adolescents, and Adults. The Guilford Press, NY, USA 366–381 (1993).
   Google Scholar
• Kessler RC, Adler LA, Barkley R et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am. J. Psych.163, 611–627 (2006).
   PubMedGoogle Scholar
• Murphy K. Psychosocial treatments for ADHD in teens and adults: a practice-friendly review. J. Clin Psychol.61(5), 607–619 (2005).
   PubMed Web of Science ®Google Scholar
• Safren SA. Cognitive–behavioural approaches to ADHD treatment in adulthood. J. Clin. Psychiatry67(Suppl. 8), 46–50 (2006).
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J. Abnorm. Psychol.111, 279–289 (2002).
   PubMed Web of Science ®Google Scholar
• Eakin L, Minde K, Hechtman L. The marital and family functioning of adults with ADHD and their spouses. J. Atten. Disord.8(1), 1–10 (2004).
   PubMedGoogle Scholar
• Wasserstein J. Diagnostic issues for adolescents and adults with ADHD. J. Clin. Psychol.61, 535–547 (2005).
   PubMed Web of Science ®Google Scholar
• Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch. Dis. Child.90, 2–7 (2005).
   PubMed Web of Science ®Google Scholar
• Hechtman L. Assessment and diagnosis of attention-deficit/hyperactivity disorder. Child Adolesc. Psychiatr. Clin. N. Am.9(3), 481–498 (2000).
   Google Scholar
• Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys, educational achievement, occupational rank, and psychiatric status. Arch. Gen. Psychiatry50, 565–576 (1993).
   PubMed Web of Science ®Google Scholar
• Faraone SV. Genetics of adult attention-deficit/hyperactivity disorder. Child Adolesc. Psychiatr. Clin N. Am.27, 303–321 (2004).
   Google Scholar
• Barkley RA. Attention-deficit/hyperactivity disorder. In: Behavioral and Emotional Disorders in Adolescents: Nature, Assessment, and Treatment. Wolfe DA, Marsh EJ (Eds). The Guilford Press, NY, USA 91–152 (2006).
   Google Scholar
• Faraone SV, Perlis RH, Doyle AE et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry57(11), 1313–1323 (2005).
   PubMed Web of Science ®Google Scholar
• Waldman ID, Gizer IR. The genetics of attention deficit hyperactivity disorder. Clin. Psychol. Rev.26, 396–432 (2006).
   PubMed Web of Science ®Google Scholar
• Ogdie MN, Macphie L, Minassian SL et al. A genome wide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am. J. Hum. Genet.72(5), 1268–1279 (2003).
   PubMed Web of Science ®Google Scholar
• Bakker SC, van der Meulen EM, Buitelaar JK et al. A whole-genome scan in 164 Dutch sibling pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am. J. Hum. Genet.72(5), 1251–1260 (2003).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Khan SA. Candidate gene studies of attention-deficit/hyperactivity disorder. J. Clin. Psychiatry67(Suppl. 8), 13–20 (2006).
   PubMedGoogle Scholar
• Asherson P. Attention-deficit hyperactivity disorder in the post-genomic era. Eur. Child Adolesc. Psychiatry13(Suppl. 1), 50–70 (2004).
   Google Scholar
• Kim JW, Waldman ID, Faraone SV et al. Investigation of parent-of-origin effects in ADHD candidate genes. Am. J. Med. Genet. B Neuropsychiatr. Genet.144B(6), 776–780 (2007).
   PubMedGoogle Scholar
• McGough JJ. Attention-deficit/ hyperactivity disorder pharmacogenomics. J. Biol. Psychiatry57, 1367–1373 (2005).
   PubMed Web of Science ®Google Scholar
• Cook EH, Stein MA, Krasowski MD et al. Association of attention-deficit disorder and the dopamine transporter gene. Am. Hum. Genet.56(4), 993–998 (1995).
   PubMed Web of Science ®Google Scholar
• Doughtery DD, Bonab AA, Spencer TJ et al. Dopamine transporter density in patients with attention deficit hyperactivity disorders. Lancet354(9196), 2132–2133 (1999).
   PubMedGoogle Scholar
• McGough JJ, McCracken J, Swanson J et al. Pharmacogenetics of methylphenidate response in preschools with ADHD. J. Am. Acad. Child Adolesc. Psychiatry45, 1314–1322 (2006).
   PubMed Web of Science ®Google Scholar
• Kim CH, Hahn MK, Joung Y et al. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc. Natl Acad. Sci. USA103(50), 19164–19169 (2006).
   PubMed Web of Science ®Google Scholar
• Kahn RS, Khoury J, Nichols WC et al. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J. Pediatr.143(1), 104–110 (2003).
   PubMed Web of Science ®Google Scholar
• Swanson JM, Kinsbourne M, Nigg J et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol. Rev.17(1), 39–59 (2007).
   PubMed Web of Science ®Google Scholar
• Arnsten AF. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J. Clin. Psychiatry67(Suppl. 8), 7–12 (2006).
   PubMedGoogle Scholar
• Arnsten AF, Li BM. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol. Psychiatry57(11), 1377–1384 (2005).
   PubMed Web of Science ®Google Scholar
• Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J. Am. Acad. Child Adolesc. Psychiatry35(3), 264–272 (1996).
   PubMed Web of Science ®Google Scholar
• Pliszka SR. The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol. Psychiatry57(11), 1385–1390 (2005).
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Lee PP, Sharp W et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA288(14), 1740–1748 (2002).
   PubMed Web of Science ®Google Scholar
• Busch G, Valera EM, Seidman LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry57(11), 1273–1284 (2005).
   PubMedGoogle Scholar
• Seidman LJ, Valera EM, Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol. Psychiatry57, 1263–1272 (2005).
   PubMed Web of Science ®Google Scholar
• Castellanos XF, Sharp WS, Gottesman RF et al. Anatomic brain abnormalities in monozygotic twins discordant for attention deficit hyperactivity disorder. Am. J. Psychiatry160, 1693–1696 (2003).
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Valera EM, Busch G. Brain function and structure in adults with attention-deficit/hyperactivity disorder. Psychiatr. Clin. North Am.27(2), 323–347 (2004).
   PubMedGoogle Scholar
• Biederman J. Attention-deficit/ hyperactivity disorder: a selective overview. Biol. Psychiatry57(11), 1215–1220 (2005).
   PubMed Web of Science ®Google Scholar
• Thapar A, Fowler T, Rice F et al. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am. J. Psychiatry160(11), 1985–1989 (2003).
   PubMed Web of Science ®Google Scholar
• Linnet KM, Wisborg K, Obel C et al. Smoking during pregnancy and the risk for hyperkinetic disorder in offspring. Pediatrics116(2), 462–467 (2005).
   PubMed Web of Science ®Google Scholar
• Button TM, Thapar A, McGuffin P. Relationship between antisocial behavior, attention-deficit hyperactivity disorder and maternal prenatal smoking. Br. J. Psychiatry187, 155–160 (2005).
   Google Scholar
• Nigg JT, Breslau N. Prenatal smoking exposure, low birth weight, and disruptive behavior disorders. J. Am. Acad. Child Adolesc. Psychiatry46(3), 362–369 (2007).
   PubMed Web of Science ®Google Scholar
• Mick E, Biederman J, Prince J et al. Impact of low birth weight on attention-deficit hyperactivity disorder. J. Dev. Behav. Pediatr.23(1), 16–22 (2002).
   PubMed Web of Science ®Google Scholar
• Milberger S, Beiderman J, Faraone SV et al. Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: issues of gene–environment interaction. Biol. Psychiatry41(1), 65–67 (1997).
   PubMed Web of Science ®Google Scholar
• Ben Amor L, Grizenko N, Schwartz G et al. Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings. J. Psychiatry Neurosci.30(2), 120–126 (2005).
   PubMed Web of Science ®Google Scholar
• Biederman J, Milberger S, Faraone SV et al. Family–environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter’s indicators of adversity. Arch. Gen. Psychiatry52(6), 464–470 (1995).
   PubMed Web of Science ®Google Scholar
• Counts CA, Nigg JT, Stawicki JA et al. Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems. J. Am. Acad. Child Adolesc. Psychiatry44(7), 690–698 (2005).
   PubMed Web of Science ®Google Scholar
• Ford JD, Racusin R, Daviss WB et al. Trauma exposure among children with oppositional defiant disorder and attention deficit-hyperactivity disorder. J. Consult. Clin. Psychol.67(5), 786–789 (1999).
   PubMed Web of Science ®Google Scholar
• Rucklidge JJ, Brown DL, Crawford S et al. Retrospective reports of childhood trauma in adults with ADHD. J. Atten. Disord.9(4), 631–641 (2006).
   PubMedGoogle Scholar
• Wolf LE, Wasserstein, J. Adult ADHD: concluding thoughts. Ann. NY Acad. Sci.931, 396–408 (2001).
   PubMed Web of Science ®Google Scholar
• Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Child Adolesc. Psychiatr Clin. N. Am.27, 187–201 (2004).
   Google Scholar
• Doyle R. The history of adult attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr. Clin. N. Am.27, 203–214 (2004).
   Google Scholar
• American Psychiatric Association. In: Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision. American Psychiatric Association, Washington, WA, USA 84 (2000).
   Google Scholar
• Barkley RA. Attention-Deficit/Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. Guilford Press, NY, USA (1990).
   Google Scholar
• Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev. Neurother.5(4), 525–539 (2005).
   PubMedGoogle Scholar
• McGough JJ, Yang M, McCracken JT, Lynn DE. Psychiatric co-morbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am. J. Psychiatry162, 1621–1627 (2005).
   PubMed Web of Science ®Google Scholar
• Sobanski E. Psychiatric co-morbidity in adults with attention deficit/hyperactivity disorder (ADHD). Eur. Arch. Psychiatr. Neurosci256, 26–31 (2006).
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein TG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am. J. Psychiatry155(4), 493–498 (1998).
   PubMed Web of Science ®Google Scholar
• Dodson WW. Pharmacotherapy of adult ADHD. J Clin Psychol.61(5), 589–606 (2005).
   Google Scholar
• Spencer T, Biederman J, Wilens T et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry57, 456–463 (2005).
   PubMed Web of Science ®Google Scholar
• Fone KCF, Nutt DJ. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr. Opin. Pharmacol.5, 87–93 (2005).
   PubMedGoogle Scholar
• Arnsten AF. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology31, 2376–2383 (2006).
   PubMed Web of Science ®Google Scholar
• Connor DF. Psychostimulants in attention deficit hyperactivity disorder. In: Attention deficit hyperactivity disorder: from genes to patients. Gozal D, Molfese DL (Eds.). Humana Press, NJ, USA 487–527 (2005).
   Google Scholar
• Wilens TE. Mechanism of action of agents used in attention-deficit/hyperactivity disorder. J. Clin. Psychiatry67(Suppl. 8), 32–37 (2006).
   PubMed Web of Science ®Google Scholar
• Fawcett J. Sympathomimetics and dopamine receptor agonist. In: Comprehensive Textbook of Psychiatry (Volume 2). Sadock BJ, Sadock VA (Eds). Lippincott Williams & Wilkins, PA, USA 2938–2943 (2005).
   Google Scholar
• Faraone SV, Spencer T, Aleardi M et al. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J. Clin. Psychopharmacol.24, 24–29 (2004).
   PubMed Web of Science ®Google Scholar
• Kollins SH, MacDonald EK, Rush CR. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol. Biochem. Behav.68(3), 611–627 (2001).
   PubMed Web of Science ®Google Scholar
• CADDRA (Canadian ADHD Practice Guidelines). Medications for ADHD. Umesh J, Hechtman L, Mutch C (Eds). Toronto, Canada 70(2006).
   Google Scholar
• Jain U, Hechtman L, Weiss M et al. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study. J. Clin. Psychiatry68, 268–277 (2007).
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Surman C et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry59(9), 829–835 (2006).
   PubMed Web of Science ®Google Scholar
• Fallu A, Caroline R, Prinzo R et al. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder. Curr. Med. Res. Opin.22(12), 2557–2566 (2006).
   PubMed Web of Science ®Google Scholar
• Wilens TE, Spencer TJ, Biederman J. Attention deficit/hyperactivity disorder across the lifespan. Annu. Rev. Med.53, 113–131 (2002).
   PubMed Web of Science ®Google Scholar
• James RS, Sharp WS, Bastain TM et al. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. J. Am. Acad. Child Adolesc. Psychiatry40(11), 1268–1276 (2001).
   PubMed Web of Science ®Google Scholar
• Biederman J, Spencer TJ, Wilens TE et al. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr.10(Suppl. 20), 16–25 (2005).
   PubMed Web of Science ®Google Scholar
• Wilens TE, Zusman RA, Hammerness PG et al. An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension. J. Clin. Psychiatry67, 696–702 (2006).
   PubMed Web of Science ®Google Scholar
• Pliszka SR. Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety, and mechanism of action. Neuropsychol. Rev.17(1), 61–72 (2007).
   PubMed Web of Science ®Google Scholar
• Hechtman L. Attention deficit disorders. In: Comprehensive Textbook of Psychiatry (Volume 2). Sadock BJ, Sadock VA (Eds). Lippincott Williams & Wilkins, PA, USA 3183–3198 (2005).
   Google Scholar
• Arnsten AF, Dudley AG. Methylphenidate improves prefrontal cortical cognitive function through α-2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav. Brain Funct.1(1), 1–9 (2005).
   PubMedGoogle Scholar
• Barkley RA, Murphy KR, O’Connell T, Connor DF. Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder. J. Safety Res.36, 121–131 (2005).
   PubMed Web of Science ®Google Scholar
• Powers AC. The pharmacology of drugs used for the treatment of attention deficit hyperactivity disorder. In: Attention Deficits and Hyperactivity in Children and Adults: Diagnosis, Treatment, Management Accardo PJ, Blondis TA, Whitman BY, Stein MA (Eds). Marcel Dekker, Inc., NY, USA 477–511 (2000).
   Google Scholar
• Greenhill LL. Clinical effects of stimulant medication in ADHD. In: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. Soltnao MV, Arnsten AFT, Castellanos FX (Eds). Oxford University Press, NY, USA 31–57 (2001).
   Google Scholar
• Weiss M, Hechtman Trokenberg L, Weiss G. ADHD in adulthood. In: A Guide To Current Theory, Diagnosis, and Treatment. John Hopkins University Press, MD, USA 132–167 (1999).
   Google Scholar
• Arnold LE. Methylphenidate vs. amphetamine: comparative review. J. Atten. Disord.3(4), 200–211 (2000).
   Google Scholar
• Weiss M, Shingler T, Capone NM. Medication satisfaction among adults with ADHD: long term results from the Quality of Life, Effectiveness, Safety, and Tolerability (Qu.S.T.) study. Presented at: New Orleans 19th US Psychiatric & Mental Health Congress. New Orleans, Louisiana, USA, 15–19 November 2006.
   Google Scholar
• MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder. Multimodal treatment study of children with ADHD. Arch. Gen. Psychiatry56, 1073–1086 (1999).
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T. Nonstimulant treatment of adult attention-deficit/hyperactivity disorder. Child Adolesc. Psychiatr Clin. N. Am.27, 373–383 (2004).
   Google Scholar
• Weiss M, Weiss JR. A guide to the treatment of adults with ADHD. J. Clin. Psychol65(Suppl. 3), 27–37 (2004).
   Google Scholar
• Belle DJ, Ernest SC, Sauer JM et al. Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics. J. Clin. Pharmacol42, 1219–1227 (2002).
   PubMed Web of Science ®Google Scholar
• Michelson D, Adler L, Spencer T et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol. Psychiatry53, 112–120 (2003).
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Faraone SV, Michelson D et al. Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. J. Clin. Psychiatry67(3), 415–420 (2006).
   PubMed Web of Science ®Google Scholar
• Fava M, Rush J, Thase ME et al. 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J. Clin. Psychiatry7, 106–113 (2005).
   Google Scholar
• Wilens TE, Haight BR, Horrigan JP et al. Buproprion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo controlled study. Biol. Psychiatry57(7), 793–801 (2005).
   PubMed Web of Science ®Google Scholar
• Robertson MM. Attention deficit hyperactivity disorder, tics and Tourette’s syndrome: the relationship and treatment implications. A commentary. Eur. Child Adolesc. Psychiatry15(1), 1–11 (2006).
   PubMed Web of Science ®Google Scholar
• Taylor FB, Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J. Clin. Psychopharmacol21(2), 223–228 (2001).
   PubMed Web of Science ®Google Scholar
• Lopez F. ADHD: new pharmacological treatments on the horizon. J. Dev. Behav. Pediatr.27(5), 410–416 (2006).
   PubMedGoogle Scholar
• Biederman J. Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder. J. Clin. Psychiatry67(Suppl. 8), 3–6 (2006).
   Google Scholar
• Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J. Clin. Psychiatry67(4), 554–566 (2006).
   PubMed Web of Science ®Google Scholar
• Turner D. A review of the use of modafinil for attention-deficit hyperactivity disorder. Expert Rev. Neurother.6(4), 455–468 (2006).
   PubMedGoogle Scholar
• Lindsay SE, Gudelsky GA, Heaton PC. Use of modafinil for the treatment of attention deficit/hyperactivity disorder. Ann. Pharmacother.40, 1829–1833 (2006).
   PubMed Web of Science ®Google Scholar
• Barkley RA, Gordon M. Research on comorbidity, adaptive functioning, and cognitive impairments in adults with ADHD: implications for a clinical practice. In: Clinician’s Guide to Adult ADHD: Assessment and intervention. Goldstein S, Ellison AT (Eds). Academic Press, CA, USA 43–67 (2002).
   Google Scholar
• Nutt DJ, Fone K, Asherson P et al. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. (Oxford)8, 1–32 (2006).
   Google Scholar
• Prince BJ, Wilens TE. Diagnosis and treatment of adults with ADHD. In: Attention Deficits and Hyperactivity in Children and Adults: Diagnosis, Treatment, Management. Accardo PJ, Blondis TA, Whitman BY, Stein MA (Eds). Marcel Dekker Inc., NY, USA 665–682 (2000).
   Google Scholar
• Wilens TE, Prince JB, Spencer T et al. An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. Biol. Psychiatry54(1), 9–16 (2003).
   PubMed Web of Science ®Google Scholar
• Biederman J. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry65(Suppl. 3), 3–7 (2004).
   PubMed Web of Science ®Google Scholar
• Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur. Arch. Psychiatry Clin.Neurosci256, I/26–I/31 (2006).
   Google Scholar
• Hecthtman L, Etcovitch J, Platt R et al. Does multimodal treatment of ADHD decrease other diagnoses? Clin. Neurosci. Res.5, 273–282 (2005).
   Google Scholar
• Weiss M, Hechtman L, Conners K et al. A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem focused therapy for ADHD in adults. J. Clin. Psychiatry67(4), 611–619 (2006).
   PubMed Web of Science ®Google Scholar
• Wilens T. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr. Clin. North Am.27, 283–301 (2004).
   PubMed Web of Science ®Google Scholar
• Wilens TE. Impact of ADHD and its treatment on substance abuse in adults. J. Clin. Psychiatry65(Suppl. 3), 38–45 (2004).
   PubMed Web of Science ®Google Scholar
• Rapport MD, Chung KM, Shore G et al. A conceptual model of child psychopathology: implications for understanding attention deficit hyperactivity disorder and treatment efficacy. J. Child Clin. Psychol.30(1), 48–58 (2001).
   PubMed Web of Science ®Google Scholar
• Rostain AL, Ramsay RJ. A combined treatment approach for adults with ADHD: results of an open study of 43 patients. J. Atten. Disord.10(2), 150–159 (2006).
   PubMedGoogle Scholar
• Young S. A model of psychotherapy for adults with ADHD. In: Clinician’s Guide to Adult ADHD: Assessment and Intervention. Goldstein S, Ellison AT (Eds). Academic Press, CA, USA 147–158 (2002).
   Google Scholar
• Wilens TE, McDermott SP, Biederman J et al. Cognitive therapy in the treatment of adults with ADHD: a systematic chart review of 26 cases. J. Cognitive Psychother.13(3), 215–222 (1999).
   Google Scholar
• Stevenson CS, Whitmont S, Bornholt L et al. A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Austral. NZ J. Psychiatry36, 610–616 (2002).
   Google Scholar
• Safren SA, Otto MW, Sprich S et al. Cognitive–behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav. Res. Ther.43(7), 792–801 (2004).
   Web of Science ®Google Scholar
• Eakin L, Minde K, Hechtman L et al. The marital and family functioning of adults with ADHD and their spouses. J. Atten. Disord.8(1), 1–10 (2004).
   PubMedGoogle Scholar